Safety and Tolerability of Accelerated Low-Frequency Repetitive Transcranial Magnetic Stimulation Over the Primary Motor Cortex-A Pilot Study.
accelerated
low-frequency
motor cortex
neuromodulation
transcranial magnetic stimulation
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2022
2022
Historique:
received:
12
10
2021
accepted:
07
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Low-frequency repetitive transcranial magnetic stimulation (rTMS) is capable of inducing changes in the functional organization of underlying brain regions, however, often at the cost of long stimulation protocols over several weeks. As these protocols can be difficult to implement in clinical settings, the aim of the present pilot study was to show the feasibility and safety of an accelerated low-frequency rTMS protocol applying multiple sessions daily. To this purpose, nine healthy subjects received 14 sessions of rTMS (1 Hz, 30 min, 110% RMT) to the hand motor hotspot. Subjects received stimulation for either 14 days once daily [classical rTMS (c-rTMS)], 7 days twice daily (accelerated rTMS; a-rTMS), or sham stimulation for 14 days once daily (s-rTMS). Daily stimulation sessions in the a-rTMS group were delivered with a 90-min break in between. In total, 74% of rTMS sessions in the c-rTMS group, 89% in the a-rTMS group, and 98% in the s-rTMS group were free of any side effects. Brief headaches and fatigue in stimulated muscle groups were the most frequent side effects. All side effects were reported to be at maximum mild and of short duration. Thus, accelerated low-frequency rTMS of the motor cortex seems to be a safe and feasible method, previously shown to induce a functional reorganization of the motor system. By shortening treatment duration in days, this approach can potentially make rTMS protocols more accessible to a wider range of patients.
Identifiants
pubmed: 35368274
doi: 10.3389/fnins.2022.793742
pmc: PMC8971658
doi:
Types de publication
Journal Article
Langues
eng
Pagination
793742Informations de copyright
Copyright © 2022 Engelhardt, Kimmel, Raffa, Conti and Picht.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neuropsychiatr Dis Treat. 2018 Jan 17;14:309-316
pubmed: 29398915
Parkinsonism Relat Disord. 2016 Jan;22:54-61
pubmed: 26777410
Clin Neurophysiol. 2020 Feb;131(2):474-528
pubmed: 31901449
Clin Neurophysiol. 2021 Jan;132(1):269-306
pubmed: 33243615
Cogn Behav Neurol. 2004 Jun;17(2):109-17
pubmed: 15453520